Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Natasha C, Bergmann"'
Autor:
Amalie R Lanng, Lærke S Gasbjerg, Natasha C Bergmann, Sigrid Bergmann, Mads M Helsted, Matthew P Gillum, Bolette Hartmann, Jens J Holst, Tina Vilsbøll, Filip K Knop
Publikováno v:
Endocrine Connections, Vol 8, Iss 10, Pp 1372-1382 (2019)
Background: Ingestion of the calorically dense compound alcohol may cause metabolic disturbances including hypoglycaemia, hepatic steatosis and insulin resistance, but the underlying mechanisms are uncertain. The gastrointestinal tract is well recogn
Externí odkaz:
https://doaj.org/article/77e570b02809446c96f4503abc47fc8c
Autor:
Liva S L Krogh, Kristine Henriksen, Signe Stensen, Kirsa Skov-Jeppesen, Natasha C Bergmann, Joachim Størling, Mette M Rosenkilde, Bolette Hartmann, Jens J Holst, Lærke S Gasbjerg, Filip K Knop
Publikováno v:
European Journal of Endocrinology. 188
ObjectiveThe gut hormone glucose-dependent insulinotropic polypeptide (GIP) is an important regulator of glucose and bone metabolism. In rodents, the naturally occurring GIP variant, GIP(1-30)NH2, has shown similar effects as full-length GIP (GIP(1-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a404840649d866f6f9723e84652db3bc
https://doi.org/10.1093/ejendo/lvac015
https://doi.org/10.1093/ejendo/lvac015
Autor:
Tina Vilsbøll, Sebastian M. Nguyen Heimbürger, Filip K. Knop, Thomas F. Dejgaard, Jens J. Holst, Natasha C. Bergmann, Mikkel B. Christensen, Bjørn Hoe, Bolette Hartmann, Chris N Nielsen
Publikováno v:
Diabetologia. 64:2425-2431
Type 1 diabetes is characterised by reduced glucagon response to hypoglycaemia, increasing the risk of insulin treatment-associated hypoglycaemia known to hamper glycaemic control. We previously reported a glucagonotropic effect of exogenous glucose-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b819d1617ec2e0f8f036de979bd7ebf4
https://doi.org/10.1007/s00125-021-05547-8
https://doi.org/10.1007/s00125-021-05547-8
Autor:
Natasha C. Bergmann, Chen Zhang, Mikkel B. Christensen, Birgitte Holst, Christoffer A. Hagemann, Morten Hedegaard, Mechthilde Falkenhahn, Stefan Theis, Sebastian M. Nguyen Heimbürger, Henrik H. Hansen, Tina Jorsal, Niels Vrang, Filip K. Knop, Kristin Breitschopf, Tina Vilsbøll, Kristoffer T.G. Rigbolt, Jacob Jelsing, Stephanie Holm, Martin R. Madsen
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 106:e966-e981
Context The mechanisms underlying Roux-en-Y gastric bypass (RYGB) surgery-induced weight loss and the immediate postoperative beneficial metabolic effects associated with the operation remain uncertain. Enteroendocrine cell (EEC) secretory function h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5ef82b6a48a2ca3aa12fc4f656b064f
https://doi.org/10.1210/clinem/dgaa803
https://doi.org/10.1210/clinem/dgaa803
Autor:
Bolette Hartmann, Mikkel B. Christensen, Tina Vilsbøll, Natasha C. Bergmann, Asger Lund, Liva S.L. Krogh, Jens J. Holst, Lene Jessen, Filip K. Knop, Flemming Dela, Lærke S. Gasbjerg, Sebastian M. Nguyen Heimbürger
Publikováno v:
Diabetes Care. 43:588-596
OBJECTIVE Dual incretin receptor agonists in clinical development have shown reductions in body weight and hemoglobin A1c (HbA1c) in patients with type 2 diabetes, but the impact of glucose-dependent insulinotropic polypeptide (GIP) receptor activati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c43580b51b55666475a99c3d6e47de9
https://doi.org/10.2337/dc19-0578
https://doi.org/10.2337/dc19-0578
Autor:
Filip K. Knop, Amalie R. Lanng, Natasha C. Bergmann, Tina Vilsbøll, Matthew P. Gillum, Mads M. Helsted, Bolette Hartmann, Sigrid Bergmann, Jens J. Holst, Lærke S. Gasbjerg
Publikováno v:
Lanng, A R, Gasbjerg, L S, Bergmann, N C, Bergmann, S, Heisted, M M, Gillum, M P, Hartmann, B, Holst, J J, Vilsboll, T & Knop, F K 2019, ' Gluco-metabolic effects of oral and intravenous alcohol administration in men ', Endocrine Connections, vol. 8, no. 10, pp. 1372-1382 . https://doi.org/10.1530/EC-19-0317
Endocrine Connections
Endocrine Connections, Vol 8, Iss 10, Pp 1372-1382 (2019)
BASE-Bielefeld Academic Search Engine
Endocrine Connections
Endocrine Connections, Vol 8, Iss 10, Pp 1372-1382 (2019)
BASE-Bielefeld Academic Search Engine
Background Ingestion of the calorically dense compound alcohol may cause metabolic disturbances including hypoglycaemia, hepatic steatosis and insulin resistance, but the underlying mechanisms are uncertain. The gastrointestinal tract is well recogni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::878aa78463bd4cd8f063c98807a69f01
https://doi.org/10.1530/ec-19-0317
https://doi.org/10.1530/ec-19-0317
Autor:
Mikkel B. Christensen, Tina Vilsbøll, Natasha C. Bergmann, Emma C. E. Meessen, Bolette Hartmann, Lene Jessen, Filip K. Knop, Maria M. Andersen, Jens J. Holst, Lærke S. Gasbjerg, Asger Lund, Sigrid Bergmann
Publikováno v:
Diabetologia, 62(4), 665-675. Springer Verlag
Aims/hypothesis: Glucagon-like peptide 1 (GLP-1) reduces appetite and energy intake in humans, whereas the other incretin hormone, glucose-dependent insulinotropic polypeptide (GIP), seems to have no effect on eating behaviour. Interestingly, studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::041c35bfdcdcc965daf3af11aaff16b5
https://doi.org/10.1007/s00125-018-4810-0
https://doi.org/10.1007/s00125-018-4810-0
Autor:
Lærke S. Gasbjerg, Mette M. Rosenkilde, Amalie R. Lanng, Natasha C. Bergmann, Mikkel B. Christensen, Mads M. Helsted, Jens J. Holst, Maria Buur Nordskov Gabe, Tina Vilsbøll, Simon Veedfald, Bolette Hartmann, Alexander Hovard Sparre-Ulrich, Mette H. Jensen, Filip K. Knop, Signe Stensen
Publikováno v:
Diabetes. 68:906-917
The incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) are secreted postprandially and contribute importantly to postprandial glucose tolerance. In this study, we assessed the individual and combi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77031682421a478efe0b26e611b94765
https://doi.org/10.2337/db18-1123
https://doi.org/10.2337/db18-1123
Autor:
Simon Veedfald, Filip K. Knop, Tina Vilsbøll, Natasha C. Bergmann, Mikkel B. Christensen, Jens J. Holst
Publikováno v:
Diabetic Medicine. 38
The insulinotropic gut hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) are key factors in the regulation of normal postprandial glucose homeostasis, but in most reports, the glucose-lowering effect of G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a7c643e8c3a22d6a5b372157a0bc4d0
https://doi.org/10.1111/dme.14592
https://doi.org/10.1111/dme.14592
Autor:
Sebastian M N, Heimbürger, Bjørn, Hoe, Chris N, Nielsen, Natasha C, Bergmann, Bolette, Hartmann, Jens J, Holst, Tina, Vilsbøll, Thomas F, Dejgaard, Mikkel B, Christensen, Filip K, Knop
Publikováno v:
Diabetologia. 64(11)
Type 1 diabetes is characterised by reduced glucagon response to hypoglycaemia, increasing the risk of insulin treatment-associated hypoglycaemia known to hamper glycaemic control. We previously reported a glucagonotropic effect of exogenous glucose-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::071ee5ab19c9108d13cdaa0ce5473770
https://pubmed.ncbi.nlm.nih.gov/34405256
https://pubmed.ncbi.nlm.nih.gov/34405256